Product Details
Synonym
BAFFR, TNFRSF13C, BROMIX, CD268, CVID4, prolixin, BAFF-R
Source
Rat BAFFR, His Tag (BAR-R52H3) is expressed from human 293 cells (HEK293). It contains AA Ser 10 - Asp 69 (Accession # D4A281-1).
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 8.7 kDa. The protein migrates as 16-30 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>90% as determined by SDS-PAGE.
>95% as determined by SEC-HPLC.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE

Rat BAFFR, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).
SEC-HPLC

The purity of Rat BAFFR, His Tag (Cat. No. BAR-R52H3) was greater than 95% as determined by SEC-HPLC.
Bioactivity-ELISA

Immobilized Mouse BAFF Protein, Mouse IgG2a Fc Tag (Cat. No. BAF-M5257) at 5 μg/mL (100 μL/well) can bind Rat BAFFR, His Tag (Cat. No. BAR-R52H3) with a linear range of 10-312 ng/mL (QC tested).
Protocol
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
B-cell activating factor receptor
- Category:
- Approved Drugs:
0 Details
- Drugs in Clinical Trials:
14 Details
- Highest Development Stage:
NDA/BLA



















